Novartis India Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Novartis India Ltd. from all sources in a single place.

Load latest

Novartis India Ltd.

27 Sep 2024

825.75

-1.40%

Board Meeting

NOVARTIS INDIA LTD. - 500672 - Board Meeting Intimation for Board Meeting Intimation For The Consideration …

BSE India

NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended September 30, 2024

pdf

Novartis India Ltd.

27 Sep 2024

825.75

-1.40%

SAST

NOVARTIS INDIA LTD. - 500672 - Closure of Trading Window

BSE India

Intimation for the closure of Trading Window for the quarter ended September 30, 2024. The trading window will be closed from October 01, 2024. The trading window will open 48 hours after the said financial results for the quarter are declared to the Stock Exchange.

pdf

Novartis India Ltd.

26 Sep 2024

825.75

-1.40%

Novartis India clarifies on reports indicating Alkem's interest in it

Business Line

Stock price ended up 7 percent on reports that Alkem was in discussion with Novartis AG for the India entity.

Novartis India Ltd. is trading below its 50 day SMA of 831.6

Novartis India Ltd.

26 Sep 2024

825.75

-1.40%

Company Update

NOVARTIS INDIA LTD. - 500672 - Filing Of Clarification On The Email Received From BSE Dated …

BSE India

Filing of clarification on the email received from BSE dated September 26, 2024, on the rumor in relation to acquisition of Novartis India Limited from its Swiss Parent Company by Alkem Labs.

pdf

Novartis India Ltd.

26 Sep 2024

825.75

-1.40%

Corp. Note

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Filing of intimation u/r 39(3) for the loss of share certificate received from Company''s RTA dated September 26, 2024

pdf

Novartis India Ltd.

26 Sep 2024

825.75

-1.40%

Company Update

NOVARTIS INDIA LTD. - 500672 - Clarification sought from Novartis India Ltd

BSE India

The Exchange has sought clarification from Novartis India Ltd on September 26, 2024, with reference to news appeared in www.cnbctv18.com dated September 26, 2024 quoting "Alkem Labs in talks to acquire Novartis India from its Swiss parent" The reply is awaited.

Novartis India Ltd.

25 Sep 2024

825.75

-1.40%

Company Update

NOVARTIS INDIA LTD. - 500672 - Intimation Of Acquiring Of DESFERAL(r) (Deferoxamine) Globally From Novartis Pharma …

BSE India

The Company Novartis India Limited has been importing DESFERAL (deforoxamine) from Novartis Pharma AG and selling it in India. This intimation is filed to inform that DESFERAL (deforoxamine) is acquired by Miten Pharma globally from Novartis Pharma AG.

pdf